In AF with recent ACS or PCI, apixaban reduced bleeding vs VKAs; aspirin increased bleeding vs placebo
- PMID: 31307068
- DOI: 10.7326/ACPJ201907160-007
In AF with recent ACS or PCI, apixaban reduced bleeding vs VKAs; aspirin increased bleeding vs placebo
Comment on
-
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.N Engl J Med. 2019 Apr 18;380(16):1509-1524. doi: 10.1056/NEJMoa1817083. Epub 2019 Mar 17. N Engl J Med. 2019. PMID: 30883055 Clinical Trial.
Similar articles
-
In AF with recent ACS or PCI, apixaban improved 30-day outcomes vs. VKAs; aspirin effects varied vs. placebo.Ann Intern Med. 2020 Sep 15;173(6):JC29. doi: 10.7326/ACPJ202009150-029. Ann Intern Med. 2020. PMID: 32926823
-
An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial.Am Heart J. 2018 Jun;200:17-23. doi: 10.1016/j.ahj.2018.03.001. Epub 2018 Mar 9. Am Heart J. 2018. PMID: 29898844 Clinical Trial.
-
A drug safety evaluation of apixaban for the treatment of atrial fibrillation, acute coronary syndrome, and percutaneous coronary intervention.Expert Opin Drug Saf. 2019 Dec;18(12):1119-1125. doi: 10.1080/14740338.2019.1676723. Epub 2019 Oct 8. Expert Opin Drug Saf. 2019. PMID: 31580164 Review.
-
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial.Eur Heart J. 2014 Jan;35(4):224-32. doi: 10.1093/eurheartj/eht445. Epub 2013 Oct 20. Eur Heart J. 2014. PMID: 24144788 Clinical Trial.
-
Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?Clin Res Cardiol. 2018 Jul;107(7):533-538. doi: 10.1007/s00392-018-1242-2. Epub 2018 Apr 20. Clin Res Cardiol. 2018. PMID: 29679144 Review.
Cited by
-
Effectiveness of Early Direct Oral Anticoagulant Monotherapy within One Year of Coronary Stent Implantation in Patients with Atrial Fibrillation: A Nationwide Population-Based Study.J Clin Med. 2023 Dec 4;12(23):7487. doi: 10.3390/jcm12237487. J Clin Med. 2023. PMID: 38068538 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous